UNSPSC 51151646: Methylatropine

This classification denotes a parasympatholytic with the molecular formula C18H26NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80719I460H, chemically known as 8-azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8,8-dimethyl-, endo-(+-)- but generally known as methylatropine, which bears US NIH Compound Identifier 5861. World Health Organization schedules methylatropine in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.

UNSPSC 51151646 Methylatropine is a Commodity code that encompasses pharmaceutical preparations used in emergency medical and public health contexts. State and local governments procure this category of pharmaceutical products primarily through county health departments and public health agencies to support community health initiatives, emergency response programs, and substance-abuse intervention efforts. The scope of work includes the acquisition, storage, and distribution of medications and related medical systems designed for rapid deployment in health crises or community welfare settings. Issuing bodies under this code are predominantly county-level health departments and public health authorities rather than state departments or municipalities acting independently.

Seminole County, Florida represents the most recent documented activity under this code. The county issued an IFB (Invitation for Bid) numbered IFB60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, and quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. The procurement was structured as a fixed-fee competitive bidding process with a two-year initial term and one-year renewal option, requiring vendors to include all shipping and delivery costs in their proposals and maintain workers' compensation, commercial general liability, and professional liability insurance. Contractors must comply with drug-free workplace certification, E-Verify requirements, and federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence, with potential FEMA funding involvement introducing additional regulatory scrutiny.